Evidence map›Paper›PMID 24574269›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2014

Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.

Harini Raghu, Alice Jone, Carolina Cruz, Cheryl L Rewerts, Malinda D Frederick, Sherry Thornton, Jay L Degen, Matthew J Flick

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. A critical role for plasminogen in inflammation.The Journal of experimental medicine · 2020
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  13. Article
  14. Plasminogen-receptorJournal of thrombosis and haemostasis : JTH · 2017
    Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Harini RaghuCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Alice Jone
Carolina Cruz
Cheryl L Rewerts
Malinda D Frederick
Sherry Thornton
Jay L Degen
Matthew J Flick
Cincinnati Children's Hospital Medical Center · US

Funding

ROLE OF ANGPTL4, AN ANGIOGENIC MEDIATOR, IN ARTHRITISP30AR047363 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J. · 2001 to 2015
$9.2M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
Hemostatic factors and sickle cell diseaseR01HL112603 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J., MALIK, PUNAM · 2012 to 2016
$1.9M
Thrombin-mediated proteolysis in neuroinflammatory diseaseR01HL096126 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI DEGEN, JAY L · 2009 to 2012
$1.5M
Mechanisms linking the hemostatic protease thrombin to arthritic diseaseR01AR056990 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI FLICK, MATTHEW J. · 2009 to 2013
$1.3M
NHLBI NIH HHS HL-096126NHLBI NIH HHS R01 HL096126NHLBI NIH HHS R01 HL112603NIAMS NIH HHS AR-056990NIAMS NIH HHS P30 AR047363NIAMS NIH HHS R01 AR056990NIDDK NIH HHS P30 DK090971
6 · The paper itself

Abstract

objectiveA fundamental metric in the diagnosis of arthropathies is the pattern of joint involvement, including differences in proximal versus distal joints and patterns of symmetric or asymmetric disease. The basis for joint selectivity among arthritides and/or within a defined disease such as rheumatoid arthritis remains enigmatic. Coagulation and fibrinolytic activity are observed in both experimental animals with inflammatory joint disease and patients with inflammatory arthritis. However, the contribution of specific hemostatic factors to joint disease is not fully defined. We sought to determine the contribution of the fibrinolytic protease, plasminogen, to tumor necrosis factor α (TNFα)-driven arthritis in distinct joints in mice.

methodsThe impact of plasminogen and/or fibrinogen genetic deficiencies on arthritis progression was evaluated in Tg197 mice genetically predisposed to spontaneous, nonabating, and erosive polyarthritis due to exuberant human TNFα expression.

resultsElimination of plasminogen in Tg197 mice significantly exacerbated the incidence and severity of arthritis within the paw joints, but simultaneously and dramatically diminished the entire spectrum of pathologies within the knee joints of the same animals. These opposing outcomes were both mechanistically linked to fibrin(ogen), in that superimposing fibrinogen deficiency reversed both the proarthritic phenotype in the paws and arthritis resistance in the knees of plasminogen-deficient mice. Intriguingly, the change in disease severity in the knees, but not the paws, was associated with a plasminogen-dependent reduction in matrix metalloproteinase 9 activity.

conclusionPlasminogen is a key molecular determinant of inflammatory joint disease capable of simultaneously driving or ameliorating arthritis pathogenesis in distinct anatomic locations in the same subject.

Indexed as

AnimalsArthritis, ExperimentalDisease Models, AnimalFemaleFibrinogenJointsMaleMatrix Metalloproteinase 9MiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPlasminogenSeverity of Illness IndexTumor Necrosis Factor-alphaFibrinogenMatrix Metalloproteinase 9PlasminogenTumor Necrosis Factor-alpha

Identifiers

PMID24574269
PMCPMC4205575
OpenAlexW2106033318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.